Is TMS Therapy Covered by Insurance? Complete 2026 Guide

When chronic depression or severe anxiety fails to respond to oral antidepressant medications, patients often feel exhausted. Transcranial Magnetic Stimulation (TMS) is an FDA-cleared, non-invasive neuromodulation treatment. However, because TMS represents advanced medical technology, one practical question comes first: is TMS therapy covered by insurance?

The short answer is an overwhelming yes. In 2026, insurance coverage for TMS therapy is broader and more accessible than ever before. Commercial health insurance providers—including Blue Cross Blue Shield, Aetna, Cigna, UnitedHealthcare, and Humana—along with Medicare Part B and TRICARE, routinely cover TMS treatment when clinical guidelines are met.

At Options Psychiatry, led by board-certified psychiatrist Dr. Cyntrell Crawford, we guide patients in Reading, PA, Berks County, and across Pennsylvania through verifying coverage, securing prior authorization, and minimizing out-of-pocket costs. This guide details insurance guidelines, policy requirements by carrier, prior authorization steps, out-of-pocket costs, and denial appeal strategies.

The Direct Answer: Is TMS Therapy Covered by Insurance?

Yes. Transcranial Magnetic Stimulation is recognized by the medical community and major insurance carriers as an established, evidence-based medical treatment for treatment-resistant depression—not an experimental procedure.

As documented in clinical psychiatry literature and detailed in the medical overview of Transcranial Magnetic Stimulation on Wikipedia, TMS was cleared by the FDA in 2008 for Major Depressive Disorder (MDD). Over fifteen years of clinical practice have proven its safety and efficacy, leading to near-universal coverage policies across U.S. health insurance providers.

Insurance coverage applies primarily to an acute treatment course of 36 sessions (administered 5 days per week over 6 to 7 weeks). While Major Depressive Disorder is the primary approved diagnosis, many insurers also cover TMS for Obsessive-Compulsive Disorder (OCD) and Major Depressive Disorder with comorbid anxious distress.

Universal Medical Necessity Criteria for TMS Coverage

While specific rules vary between insurance companies, almost all payers adhere to four core medical necessity guidelines established by clinical psychiatric societies:

1. Confirmed Diagnosis of Major Depressive Disorder (MDD)

The patient must have a formal clinical diagnosis of single or recurrent Major Depressive Disorder (severe or moderate) rendered by a licensed psychiatrist or medical provider. Standardized depression rating scales (such as the PHQ-9 or HAM-D) are submitted with the authorization request to document depression severity.

2. Failure of Prior Antidepressant Medications (Treatment Resistance)

Insurance policies require documentation that oral antidepressant medications did not provide adequate therapeutic relief or caused unmanageable side effects:

• Number of Trials: Commercial plans generally require documented failure of 2 to 4 different antidepressant trials during the current depressive episode.
• Adequate Dose and Duration: Medications must have been taken at maximum therapeutic dosages for a minimum of 4 to 8 weeks per trial.
• Class Variation: Trials usually need to span at least two distinct pharmacological classes (such as SSRIs, SNRIs, bupropion, or atypical antipsychotic augmentations).

3. History of Evidence-Based Psychotherapy

Most commercial insurance policies (such as Aetna and Cigna) require confirmation that the patient engaged in a trial of evidence-based psychotherapy (such as Cognitive Behavioral Therapy) without achieving full symptom remission.

4. Absence of Medical Contraindications

For patient safety, candidates must be cleared of non-removable conductive or ferromagnetic metals in or near the head (such as metallic brain implants or aneurysm clips). Standard dental fillings and braces are safe and allowed. For a complete safety overview, review our clinical guides on who is eligible for TMS therapy and TMS therapy safety standards.

Coverage Breakdown by Major Insurance Carriers

Understanding how specific insurance companies handle TMS therapy helps set clear expectations before starting care. Here is an overview of major health plans in 2026:

1. Blue Cross Blue Shield (BCBS / Highmark / Independence Blue Cross)

Blue Cross Blue Shield plans across Pennsylvania offer comprehensive TMS coverage for adults (ages 18 and older) with treatment-resistant MDD. BCBS typically requires failure of 2 to 4 antidepressant trials across different classes and participation in psychotherapy. Highmark BCBS and Independence Blue Cross routinely approve initial 36-session treatment series upon receiving complete medical records.

2. Aetna

Aetna has clear clinical policy bulletins regarding TMS coverage. Aetna requires documented failure of at least 2 different antidepressant classes at therapeutic doses and a trial of psychotherapy. For detailed insights into Aetna authorization guidelines, read our dedicated article on Aetna TMS therapy coverage at Options Psychiatry.

3. Cigna (Evernorth)

Cigna covers TMS therapy under behavioral health benefits for patients diagnosed with severe MDD who have tried 2 or more antidepressant trials without adequate response. Cigna also evaluates prior trial intolerance due to adverse side effects when medical records are provided.

4. UnitedHealthcare (Optum)

UnitedHealthcare / Optum Behavioral Health covers TMS for patients who meet DSM-5 diagnostic criteria for severe MDD and have demonstrated treatment resistance to at least 2 oral antidepressant regimens. UHC also reviews requests for OCD TMS treatment protocols on a case-by-case basis.

5. Medicare & Medicare Advantage

Medicare Part B covers 80% of the Medicare-approved amount for TMS therapy once your annual Part B deductible is met, provided the treatment is administered by a qualified medical provider. The remaining 20% is typically covered by supplemental insurance (Medigap). Medicare Advantage (Part C) plans are legally required to offer coverage at least equal to Original Medicare. Learn more in our overview of Medicare mental health coverage.

6. TRICARE

TRICARE provides robust coverage for active-duty service members, retirees, and dependents diagnosed with Major Depressive Disorder who have not responded to a minimum of two antidepressant trials. Read our full breakdown of TRICARE TMS coverage in Reading, PA.

7. Pennsylvania Medicaid (HealthChoices)

Pennsylvania Medicaid managed care organizations (MCOs) provide coverage for TMS therapy when prior authorization criteria are satisfied. Options Psychiatry assists Medicaid recipients in navigating authorization requirements whenever applicable.

2026 Insurance Coverage Comparison Matrix

The table below summarizes typical insurance coverage requirements across primary health insurance carriers:

Step-by-Step Prior Authorization (PA) Process

Prior authorization is the administrative approval process where your insurance carrier reviews medical documentation to confirm that TMS therapy is medically necessary before treatment begins. At Options Psychiatry, we handle all administrative work so you can focus on recovery:

1. Comprehensive Psychiatric Evaluation: Dr. Cyntrell Crawford conducts a diagnostic evaluation to confirm MDD severity, score rating scales, and evaluate medical history.
2. Pharmacy & Treatment History Verification: We collect exact records of your past antidepressant medications, dosages, trial durations, side effects, and therapy history.
3. Prior Authorization Submission: Our intake department submits a detailed authorization packet directly to your insurance company's medical management team.
4. Insurance Review Period: Insurers typically issue formal approval within 3 to 10 business days. Expedited reviews are available for urgent cases.
5. Treatment Scheduling: Once authorization is confirmed, your 36-session TMS treatment course is scheduled at our clinic in Reading, PA.

Out-of-Pocket Costs, Deductibles, and Copays

When insurance covers TMS therapy, what are your actual out-of-pocket expenses?

Because TMS is billed as an outpatient medical procedure (CPT codes 90867, 90868, and 90869), your personal cost depends on your individual insurance plan design:

• Annual Deductible: If you have not met your annual plan deductible, payments for initial TMS sessions apply toward satisfying your deductible.
• Copayments & Coinsurance: Once your deductible is satisfied, you are responsible only for your designated specialist copay or coinsurance percentage (typically 10% to 20% of the contracted rate) per session.
• Out-of-Pocket Maximum: Once your total medical expenses reach your plan's annual out-of-pocket maximum, insurance pays 100% of remaining TMS session costs for the rest of the calendar year.

For detailed financial planning guidance, review our cost analysis on how much TMS therapy costs with and without insurance.

What to Do If Your TMS Insurance Claim Is Denied

If an initial prior authorization request is denied, do not be discouraged. Initial denials usually result from minor paperwork gaps—such as missing pharmacy refill dates or incomplete side-effect records.

At Options Psychiatry, our team actively advocates for our patients through structured appeal procedures:

• Peer-to-Peer Medical Review: Dr. Cyntrell Crawford speaks directly with the insurance medical director to explain your clinical history and justify treatment necessity.
• Formal Written Appeal: We submit supplemental clinical records, pharmacy dispensing logs, and published psychiatric research demonstrating treatment necessity.
• Expedited Reconsideration: In cases of severe clinical distress, expedited appeals yield revised authorization decisions within 24 to 48 hours.

TMS Coverage vs. Spravato® & ECT Coverage

Patients comparing advanced depression therapies often ask how TMS insurance coverage compares to other interventional treatments:

• TMS Therapy vs. Spravato® (Esketamine): Both TMS and Spravato® enjoy widespread insurance coverage for treatment-resistant depression. However, Spravato® requires prescription co-pays and mandatory 2-hour clinical observation periods under REMS guidelines. Read our comparative guides on Spravato® insurance coverage guidelines and TMS therapy vs. Spravato® comparison.
• TMS Therapy vs. Electroconvulsive Therapy (ECT): While ECT is covered, it requires general anesthesia, hospital admission, and carries risk of transient memory loss. TMS is performed in an outpatient office setting with zero memory impairment, allowing patients to drive themselves to and from appointments immediately.

Accessing Covered TMS Care at Options Psychiatry

If you or a loved one is struggling with severe depression or anxiety that has not responded to traditional medications, you do not have to navigate insurance hurdles alone.

At Options Psychiatry, our medical team combines clinical excellence with patient advocacy. Located in Reading, PA, our clinic offers FDA-cleared TMS therapy, psychiatric medication management, and specialized counseling. We serve patients across Berks, Lancaster, Montgomery, Chester, and surrounding Pennsylvania counties.

Whether you need an in-person evaluation at our TMS clinic in Reading, PA or a consultation with an expert psychiatrist in Reading, PA, we ensure your insurance benefits are maximized.

Frequently Asked Questions (FAQ)

Take the Next Step Toward Insurance-Covered Healing

Do not let concerns over insurance coverage stand between you and transformative mental health treatment. Effective, evidence-based TMS therapy is covered by insurance, and our experienced team is here to handle every detail for you.

Take control of your mental health today. Contact Options Psychiatry to schedule your comprehensive psychiatric evaluation and insurance verification.